Group 1 - The company, Ying Tai Medical (01501), announced a conditional partnership agreement with Huige Health to establish the Huige Guangtai Fund, in which it will invest as a limited partner [1] - The company plans to invest up to RMB 110 million in the Huige Guangtai Fund, with an initial contribution of RMB 50 million [1] - The total expected subscription amount for the Huige Guangtai Fund is up to RMB 350 million, with an initial subscription amount of RMB 121 million [1] Group 2 - The primary objective of the Huige Guangtai Fund is to achieve investment returns through equity investments in companies within the medical device sector [1] - As of the announcement date, the Huige Guangtai Fund has not identified any investment targets [1] - The board believes that the investment in the Huige Guangtai Fund presents an opportunity for the company to enhance its strategic development in the medical and biotechnology sectors, improve competitiveness, and solidify its market position [1]